524748 — Link Pharmachem Balance Sheet
0.000.00%
- IN₹168.30m
- IN₹225.48m
- IN₹254.33m
- 74
- 55
- 50
- 66
Annual balance sheet for Link Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PRESS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 48.9 | 9.36 | 2.16 | 0.894 | 0.645 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 56.3 | 54.1 | 37 | 51.6 | 50.3 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 151 | 136 | 175 | 115 | 112 |
Net Property, Plant And Equipment | 87.1 | 90 | 90 | 99.4 | 92.8 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 260 | 290 | 325 | 260 | 233 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 92.8 | 106 | 145 | 110 | 101 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 135 | 145 | 174 | 122 | 106 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 126 | 145 | 150 | 137 | 127 |
Total Liabilities & Shareholders' Equity | 260 | 290 | 325 | 260 | 233 |
Total Common Shares Outstanding |